Allred Capital Management, LLC Novo Nordisk A S Transaction History

Allred Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $9,080 - $10,871	74 Added 2.93%	2,603 $371,000
Q1 2024 Apr 16, 2024	BUY	$102.11 - $135.92 $258,236 - $343,741	2,529 New	2,529 $324,000
Q2 2021 Aug 05, 2021	SELL	$67.66 - $84.76 $4,668 - $5,848	-69 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$67.06 - $75.82 $134 - $151	2 Added 2.99%	69 $4,000
Q1 2020 Apr 17, 2020	BUY	$49.46 - $64.78 $2,027 - $2,655	41 Added 157.69%	67 $4.03 Million
Q4 2019 Jan 13, 2020	BUY	$49.86 - $58.26 $1,296 - $1,514	26 New	26 $1,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Allred Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Allred Capital Management, LLC with notifications on news.